TABLE 3.
Copy numbers detected from 20 ng DNA derived from saliva samples in each primer/probe sets
| Saliva samples from HPV-HNSCC patients | |||
|---|---|---|---|
| # | E7 | BR E1-5 | HR E5L2-4 |
| 1 | 3E+05 | 866 000 | 322 000 |
| 2 | 50 000 | 118 000 | 52 500 |
| 3 | 48 500 | 47 600 | 25 800 |
| 4 | 46 500 | 104 000 | 33 200 |
| 5 | 14 700 | N/A | N/A |
| 6 | 7320 | N/A | N/A |
| 7 | 4950 | 9790 | 9670 |
| 8 | 1570 | 3590 | 2510 |
| 9 | 1020 | 2600 | 1590 |
| 10 | 981 | N/A | N/A |
| 11 | 521 | N/A | N/A |
| 12 | 155 | 127 | 86.7 |
| 13 | 140 | 290 | 53.1 |
| 14 | 82.7 | 114 | 31.1 |
| 15 | 62.6 | 160 | 49.7 |
| 16 | 41.2 | 121 | 41.3 |
| 17 | 14.1 | 67.4 | 15.8 |
| 18 | 9.69 | 15.8 | 2.61 |
| 19 | 8.17 | 61.1 | 26.9 |
| 20 | 6.5 | 30.9 | 13.4 |
| 21 | 4.02 | 25.7 | 6.54 |
| 22 | 2.52 | 2.68 | 1.16 |
| 23 | 0.986 | 1.82 | N/A |
| 24 | N/A | 14.4 | N/A |
| 25 | N/A | 2.76 | N/A |
| 26 | N/A | N/A | 2.15 |
| 27 | N/A | 2.17 | 1.19 |
| 28 | N/A | N/A | N/A |
| Saliva samples from nontumor patients | |||
| # | E7 | BR E1-5 | HR E5L2-4 |
| 1 | N/A | N/A | N/A |
| 2 | N/A | N/A | N/A |
| 3 | N/A | N/A | N/A |
| 4 | N/A | N/A | N/A |
| 5 | N/A | N/A | N/A |
| 6 | N/A | N/A | N/A |
| 7 | N/A | N/A | N/A |
| 8 | N/A | N/A | N/A |
| 9 | N/A | N/A | N/A |
| 10 | N/A | N/A | N/A |
| 11 | N/A | N/A | N/A |
| 12 | N/A | N/A | N/A |
| 13 | N/A | N/A | N/A |
| 14 | N/A | N/A | N/A |
| 15 | N/A | N/A | N/A |